1LVO
| Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain | Descriptor: | (4R)-2-METHYLPENTANE-2,4-DIOL, 1,4-DIETHYLENE DIOXIDE, Replicase, ... | Authors: | Anand, K, Palm, G.J, Mesters, J.R, Siddell, S.G, Ziebuhr, J, Hilgenfeld, R. | Deposit date: | 2002-05-29 | Release date: | 2002-07-17 | Last modified: | 2024-03-13 | Method: | X-RAY DIFFRACTION (1.96 Å) | Cite: | Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. EMBO J., 21, 2002
|
|
2H85
| Crystal Structure of Nsp 15 from SARS | Descriptor: | Putative orf1ab polyprotein | Authors: | Ricagno, S, Egloff, M.P, Ulferts, R, Coutard, B, Nurizzo, D, Campanacci, V, Cambillau, C, Ziebuhr, J, Canard, B. | Deposit date: | 2006-06-06 | Release date: | 2006-08-15 | Last modified: | 2024-02-14 | Method: | X-RAY DIFFRACTION (2.6 Å) | Cite: | Crystal structure and mechanistic determinants of SARS coronavirus nonstructural protein 15 define an endoribonuclease family. Proc.Natl.Acad.Sci.Usa, 103, 2006
|
|
1P9U
| Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of anti-SARS Drugs | Descriptor: | (4R)-2-METHYLPENTANE-2,4-DIOL, PHQ-VNSTLQ-CHLOROMETHYLKETONE INHIBITOR, SULFATE ION, ... | Authors: | Anand, K, Ziebuhr, J, Wadhwani, P, Mesters, J.R, Hilgenfeld, R. | Deposit date: | 2003-05-12 | Release date: | 2003-05-20 | Last modified: | 2024-10-30 | Method: | X-RAY DIFFRACTION (2.37 Å) | Cite: | Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of anti-SARS Drugs Science, 300, 2003
|
|
1P9S
| Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of anti-SARS Drugs | Descriptor: | 1,4-DIETHYLENE DIOXIDE, Replicase polyprotein 1ab | Authors: | Anand, K, Ziebuhr, J, Wadhwani, P, Mesters, J.R, Hilgenfeld, R. | Deposit date: | 2003-05-12 | Release date: | 2003-05-20 | Last modified: | 2024-10-30 | Method: | X-RAY DIFFRACTION (2.54 Å) | Cite: | Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of anti-SARS Drugs Science, 300, 2003
|
|